rs144915847
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_025219.3(DNAJC5):c.419C>T(p.Ala140Val) variant causes a missense change. The variant allele was found at a frequency of 0.000075 in 1,614,048 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_025219.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAJC5 | ENST00000360864.9 | c.419C>T | p.Ala140Val | missense_variant | Exon 4 of 5 | 1 | NM_025219.3 | ENSP00000354111.4 | ||
DNAJC5 | ENST00000470551.1 | n.419C>T | non_coding_transcript_exon_variant | Exon 4 of 6 | 2 | ENSP00000434744.1 | ||||
DNAJC5 | ENST00000703637.1 | n.419C>T | non_coding_transcript_exon_variant | Exon 4 of 6 | ENSP00000515413.1 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152258Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000319 AC: 8AN: 250832Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135794
GnomAD4 exome AF: 0.0000759 AC: 111AN: 1461790Hom.: 0 Cov.: 32 AF XY: 0.0000701 AC XY: 51AN XY: 727188
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152258Hom.: 0 Cov.: 33 AF XY: 0.0000941 AC XY: 7AN XY: 74388
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant summary: DNAJC5 c.419C>T (p.Ala140Val) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00017 in 359436 control chromosomes, predominantly at a frequency of 0.00048 (i.e., 52 heterozygotes) within the Japanese subpopulation in the jMorp and gnomAD databases (Tadaka_2021). Although the available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance, the allele frequency in the Japanese subpopulation suggests this variant may be benign. c.419C>T has been reported in the literature in at least one individual affected with early-onset Parkinson's disease (e.g., Li_2020), however without strong evidence for causality (e.g., lack of co-segregation and co-occurrence data). This report therefore does not provide unequivocal conclusions about association of the variant with Ceroid Lipofuscinosis, Neuronal, 4. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 32662538, 33179747). One submitter has reported clinical-significance assessments for this variant to ClinVar after 2014 and has classified the variant as likely benign. Based on the evidence outlined above, the variant was classified as VUS-possibly benign. -
not provided Uncertain:1
p.Ala140Val (GCG>GTG): c.419 C>T in exon 4 of the DNAJC5 gene (NM_025219.2). The A140V variant has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. It was not observed with any significant frequency in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project. The A140V variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position that is conserved through mammals. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic mutation or a rare benign variant. The variant is found in EPILEPSY panel(s). -
Neuronal ceroid lipofuscinosis Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at